Viewing Study NCT02974933


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-02-24 @ 10:06 AM
Study NCT ID: NCT02974933
Status: UNKNOWN
Last Update Posted: 2017-02-17
First Post: 2016-11-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer
Sponsor: Wuling Ou
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: HubeiCH
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None UNKNOWN View